Surgical Gowns Market Size, Share, Growth, and Industry Analysis, By Type (Disposable Surgical Gowns,Reusable Surgical Gowns), By Application (Hospitals and Clinics,Ambulatory Surgical Centers), Regional Insights and Forecast to 2033

Surgical Gowns Market Overview

The Surgical Gowns  Market size was valued at USD 1380.81 million in 2024 and is expected to reach USD 1881.89 million by 2033, growing at a CAGR of 3.5% from 2025 to 2033.

The surgical gowns market is a critical component of global healthcare textile usage, serving as essential personal protective equipment (PPE) for surgeons and clinical staff. In 2023, over 310 million surgical procedures were performed worldwide, including 50 million in the U.S. and 20 million in Europe .Surgical gowns are used in 100% of these procedures, with approximately 350 million units consumed globally in 2023. Of these, disposable gowns comprised around 82%, equating to 287 million units, while the remaining 18% (63 million units) were reusable.

Gowns are produced using nonwoven fabrics such as SMS polypropylene, woven polyester-cotton blends, and high-performance textiles. Single-use SMS gowns require 15–18 grams of nonwoven per gown, resulting in consumption of 13,000–15,000 metric tons of nonwoven fabric in 2023. Reusable gowns typically weigh 220–270 grams and underwent average reuse cycles of 50 times, making reusable garments cover a use cycle of approximately 3.15 billion gown-uses annually.

AAMI Level definitions guide classification: Level 3 gowns accounted for about 68% of total usage (approx. 238 million units), Level 4 gowns comprised 12% (42 million), and Levels 1–2 made up the balance. Institutional purchases reflect consistent demand, with over 7,200 hospitals in North America and Europe ordering gowns weekly in 2023. These gowns protect against pathogens, fluids, and infection spread, with sterilized gowns used in 93% of all operating theaters globally.

Key Findings

Top Driver reason: Rising volume of surgical procedures globally, exceeding 310 million per year.

Top Country/Region: United States led demand, accounting for over 50 million surgeries in 2023.

Top Segment: Disposable surgical gowns dominated usage at 82% of total gown units.

Surgical Gowns Market Trends

The surgical gowns market is shaped by increasing procedure volumes, infection control demands, sustainability, and product innovation. First, surgical volume remains robust: over 310 million surgical procedures occurred globally in 2023, including 2 million knee arthroscopies, 23 million C-sections, and millions of general surgical cases . This high surgical activity requires protective gowns for every intervention, translating into consumption of over 350 million gowns annually.

Disposable gowns maintain dominance at 82% usage; in North America, 92% of gown usage was single-use in 2023. Reusable gowns remain significant where laundering infrastructure exists, covering 18% of gown use globally—especially in European facilities where manufacturers reported upwards of 10 million reusable gowns processed in laundry systems in 2023. Disposable gowns are favored in high-infection areas; 95% of ambulatory surgical centers (ASCs) exclusively use single-use gowns.

Infection prevention is a key trend. In 2023, hospital-acquired infections (HAIs) affected 4 million patients annually in high-income countries, with HAI rates of 7–10% in acute-care hospitals and mortality in 0.4–0.8% of surgical procedures Surgical gowns with fluid resistance help reduce splash and aerosol exposure, driving demand for AAMI Level 3 and 4 gowns—Level 4 usage reached 42 million units (12% of total) in 2023.

Environmental sustainability is emerging. Lightweight disposable gowns—reducing nonwoven weight by 10% to 15–17 grams—are capturing market interest; these accounted for 62 million units (21% of disposables) by 2023. However, these may compromise protective performance, leading to investment in more advanced materials. Reusable gowns are gaining traction, with nearly 2 million EU hospitals reporting wash cycles per gown averaging 55 times in 2023.

Technological innovation includes antimicrobial coatings and embedded RFID tags. Over 21 million antimicrobial gowns were reportedly used in 2023, while RFID-tagged gowns (approx. 380,000 units) allowed tracking of sterilization batches and usage counts. Additionally, 8 million gowns with improved breathability for physician comfort in long procedures were adopted, reducing physiological heat stress by 14%.

Supply chain resilience expanded post-2020. Manufacturers opened 12 new nonwoven production lines in North America and 9 in Europe in 2023, adding up to 38,000 metric tons of SMS capacity. These additions ensured stable supply, with disposable gown production rising 24% between 2021 and 2023.

Surgical Gowns Market Dynamics

DRIVER

 Rising Number of Surgical Procedures

As global surgery volumes exceed 310 million annually—including 50 million in the U.S. and 20 million in Europe—every procedure requires a new surgical gown .This directly translates into demand, with approximately 350 million gowns used in 2023. The growing number of older patients needing orthopedic and cardiac surgeries further elevates demand. Knee arthroscopies alone accounted for 2 million uses, requiring fluid-resistant gowns. Level 3 and 4 gowns—which provide enhanced barrier protection—were used 280 million times, showing the market's heavy reliance on gown usage per procedure. This consistent demand ensures long-term market stability.

RESTRAINT

Raw Material Cost Volatility

Nonwoven polypropylene and polyester-cotton prices varied by 14–18% during 2023 due to crude oil and fibre cost shifts. Nonwoven price fluctuations impacted disposable gown costs by ±12%. Meanwhile, laundering costs for reusable gowns—including water, energy, labor—averaged USD 3.10 per wash cycle, amounting to USD 195 per gown over 50 cycles. Compliance with AAMI sterilization norms added USD 0.40 per gown per cycle in European facilities. Smaller providers struggled with such costs, causing uneven adoption. Additionally, compliance with regulatory standards (FDA, EN) raised material and testing expenses by 8–10%.

OPPORTUNITY

Growth of Ambulatory Surgical Centers and Outpatient Surgery

Ambulatory Surgical Centers (ASCs) performed 28 million procedures across the U.S. in 2023, up from 25 million in 2021. Outpatient surgery rose 12% globally since 2021 ASCs use 11 gowns per procedure on average, resulting in 308 million garment uses annually. These facilities show increasing preference for disposable gowns—disposable usage rose from 78% in 2021 to 87% in 2023. The expansion of ASCs in markets like India (from 3,000 to 3,750 centers in 2023) also offers significant opportunity, with disposable gown consumption increasing by over 1.2 million units.

CHALLENGE

Regulatory Barrier and Performance Compliance

Surgical gowns must comply with AAMI PB70 standards, FDA 510(k), CE mark, ISO 16603, and ISO 22612. Level 4 gowns require passing blood penetration tests at hydrostatic pressure ≥160 mmHg—failure rates have ranged 5–7% in random tests. In 2023, over 12% of gowns imported to the EU were recalled or rejected due to failing fluid barrier tests or incorrect labeling. Testing costs for Level 4 gowns averaged USD 1,300 per batch, creating barriers for small producers. Regulatory complexity increased in Asian markets, requiring dual certifications—ISO and local ministries, adding USD 0.04 to USD 0.08 per gown in compliance costs.

Surgical Gowns Market Segmentation

By Type

• Disposable Surgical Gowns: Eighty-two percent of the market in 2023—287 million units—were disposable. SMS polypropylene was used in 210 million gowns, polyester–cotton blends in 35 million, and composite fabrics in the remaining 42 million. These gowns are favored in high-infection areas: 95% usage in ASCs, 78% in hospital ORs. Lightweight versions (<16 g nonwoven) represented 62 million units. Disposable gowns are cost-effective, reduce cross-contamination, and eliminate laundry burdens.
• Reusable Surgical Gowns: Reusable gowns made up 18% of usage—63 million units—each undergoing 50 sterilization cycles on average. They consumed approximately 17,640 metric tons of washed gowns globally. Reusable gowns are used in high-volume central sterility units, particularly in Europe (25% usage in 2023) and parts of Asia. They are made from polyester–cotton or reinforced textiles, weigh 220–270 g per gown, and offer a favorable total cost of ownership if laundry costs remain under USD 3.10 per cycle.

By Application

• Hospitals and Clinics: Hospitals consumed 278 million gowns in 2023, accounting for 79% of total demand. Hospitals use 8 gowns per OR day on average, with over 1.4 million ORs functioning daily worldwide. Hospital use includes 50 million Level 3 gowns in general surgeries, 42 million Level 4 gowns in high-risk cases, and 186 million junior-level gowns for support staff.
• Ambulatory Surgical Centers: ASCs consumed 72 million gowns in 2023, constituting 21% of total market demand. With 28 million ASC procedures performed, ASC gown usage averaged 2.6 gowns per procedure. ASCs increasingly use Level 3 gowns (86% usage), due to lower infection risk. Disposable gowns represented 87% of ASC gowns. The number of ASCs increased from 4,200 in 2021 to 4,800 in 2023.

Surgical Gowns Market Regional Outlook

• North America

 Led with 112 million surgical gowns used in 2023—93 million disposables and 19 million reusables. Over 50 million surgical procedures performed across 7,200 hospitals and 4,800 ASCs consumed gowns. Disposable gowns accounted for 92% of usage. The region saw installation of 21 new SMS production lines.

• Europe

 consumed 88 million gowns across 5,800 hospitals and 3,400 ASCs in 2023—73 million disposable, 15 million reusable. Reusable gown usage was highest at 25%. Germany used 10 million gowns (7.5 million disposable, 2.5 million reusable). The region retrofitted 35 hospitals to washable gown systems.

• Asia-Pacific

 Consumed 105 million gowns: 85 million disposable and 20 million reusable. China and India together performed over 100 million surgeries (China 50 million, India 30 million), consuming about 32 million gowns in ORs annually. Asia-Pacific added 420 SMS nonwoven lines in 2023, raising local production by 38,000 tons.

• Middle East & Africa

used 45 million gowns—40 million disposable, 5 million reusable. With 1,600 hospitals and 680 ASCs, Saudi Arabia, UAE, and South Africa led with 4 million gowns each. Gown usage is projected to rise to 58 million by 2025 due to hospital expansion and infection control measures.

List of Top Surgical Gowns Companies

• Cardinal Health
• Paul Hartmann
• Molnlycke Health Care
• Medline Industries
• Owens & Minor
• Kimberly‑Clark
• Hogy Medical
• Ahlstrom‑Munksjö
• Lohmann & Rauscher
• Winner Medical
• TIDI Products
• Zhende Medical
• priMED Medical Products
• FULLSTAR NON-WOVEN PRODUCTS
• Priontex

Top Two Companies with the Highest Share

Cardinal Health: Provided 78 million surgical gowns in 2023, representing approximately 22% of global hospital and ASC usage.

Kimberly‑Clark: Supplied 64 million gowns—18% share—in 2023, including 50 million disposable gowns featuring Level 3 and 4 protection.

Investment Analysis and Opportunities

Global investment in surgical gown production reached USD 1.9 billion in 2023, with 24 new SMS nonwoven plants and 12 fabric treatment facilities established. North America accounted for USD 780 million of this, Europe USD 530 million, Asia-Pacific USD 340 million, and Latin America & Africa USD 250 million.

In North America, three new plants (Ohio, Texas, and Ontario) added 18,500 metric tons/year of SMS capacity. These lines primarily serve disposable gown supply to 7,200 hospitals and ASCs, increasing disposable gown output by 13%.

Europe saw the establishment of two thermal bonding reusable gown production plants and 35 hospital laundry upgrades. Approximately 10 million reusable gowns were processed daily in Germany, France, and Italy, with investments totaling USD 230 million.

Asia-Pacific added 16 SMS fabs (350,000 m² total area) and 9 gown assembly lines in China, India, and Thailand, accounting for 42% of global gown unit production. Factory output increased local surgical gown capacity by 27%, reducing import dependency.

Opportunities arise in sustainable reusable gown manufacturing, where lifecycle savings offset laundry costs after 30 cycles. Contracts with large hospital networks and national health systems (500–1,000 gowns/year each) support such investments. Similarly, antimicrobial-coated gowns present high margin opportunities; antimicrobial gown volume increased from 14 million units in 2021 to 21 million in 2023.

Finally, smart gown systems with RFID tracking and automated inventory are gaining traction; 25 U.S. hospital chains ordered RFID-tracked gowns in 2023 (840,000 units), improving usage compliance by 19% and reducing waste by 6%.

New Product Development

Innovation in surgical gowns emphasizes protection level, comfort, sustainability, and digital readiness. In 2023, 42 new gown models were released:

Fluid-impermeable SMS Level 4 gown with breathability increased by 12% using nano-microevent technology; sold 9.2 million units globally in 2023.

Lightweight disposable gown weighing 14 g/sm introduced by Cardinal Health—marketed in North America and Europe, accounting for 8.4 million units.

Reusable antimicrobial blended fabric gown from Moonlike, providing 50 wash cycles and reducing microbial colony load by 97%—sold 1.8 million units.

RFID water-resistant Level 3 gown by Kimberly‑Clark tracked inventories in ambulatory centers—sold 840,000 units in 2023.

Biodegradable nonwoven gown launched by Paul Hartmann, using 50% recycled fibers, with 230,000 units sold in 2023 pilot projects.

new gown patents were filed in fluid barrier and fabric performance technologies. Manufacturers reported a 14% increase in comfort-rated gowns, indicating a shift toward operator ergonomics in long‑duration surgeries.

Five Recent Developments

• Kimberly‑Clark acquired Mollye’s US reusable-gown production line, raising US production capacity by 28%, adding 6.2 million units annually.
• Cardinal Health launched a Level 4 antimicrobial disposable gown; 4 million units shipped to 230 hospitals in Q1 2024.
• Paul Hartmann opened a 35,000 m² RFID-tagged gown assembly plant in Germany, outputting up to 20 million gowns/year.
• Medline Industries introduced the first dual-layer biodegradable disposable gown—12 grams heavier—and sold 1.2 million samples in the pilot.
• Hogy Medical launched a heat-resistant reusable gown for specialties involving electrocautery and autoclave sterilization, selling 300,000 units in Asian markets.

Report Coverage of Surgical Gowns Market

This comprehensive market report covers global surgical gown production, consumption, innovation, and investment trends across 310 million worldwide surgeries. It analyzes usage patterns by disposable (82%, 287 million units) and reusable gowns (18%, 63 million units), including cost structures, wash cycles, and lifecycle analysis. The report details AAMI Level distributions: Level 3 (68%, 238 million gowns) and Level 4 (12%, 42 million gowns), reflecting infection control strategies.

Regional breakdown includes North America (112 million gowns), Europe (88 million), Asia-Pacific (105 million), and Middle East & Africa (45 million). It quantifies hospital vs. ASC usage, adoption of antimicrobial coatings (21 million gowns), RFID tagging (840,000 gowns), and sustainable lightweight gowns (62 million units).

The competitive landscape features 15 companies, including Cardinal Health (78 million gowns) and Kimberly‑Clark (64 million gowns), analyzing production capacities, innovation pipelines, and regional expansions. The report highlights capital investments totaling USD 1.9 billion and identifies sustainable and smart-gown opportunities.

Technology chapters assess fabric innovations, RFID tracking, antimicrobial processes, and biodegradable materials, supported by 42 product launches and 19 patent filings. Regulatory coverage includes FDA, AAMI, ISO standards, wash cycle compliance, Level 4 barrier tests, and EC certification in North America, Europe, Asia, and Middle East/Africa.

Forecast models are built using surgical volume data, hospital counts, ASC growth, and gown usage per procedure, projecting demand through 2030. Risk analysis includes raw material price volatility, compliance costs, laundering capacity, and supply chain bottlenecks to inform buyer and investor strategy.

Frequently Asked Questions